Brilhante, D. et al. 2019. Iron Metabolism, Biomarkers, Iron Overload and Chelation: Consensus in Myelodysplastic Syndromes. Internal Medicine. 26, 3 (Sep. 2019), 223–231. DOI:https://doi.org/10.24950/rspmi/Revisao/225/18/3/2019.